Search for: "In Re Vitamins Antitrust Litigation" Results 21 - 32 of 32
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Mar 2015, 7:17 am by Rachel, Law Clerk and Office Manager
Lawyers, surgeons make list of jobs being replaced by computersNet neutrality wins: FCC votes to classify Internet as a public utility  Legal Ethics and Social Media: What Pre-Litigation Advice May an Attorney Provide to His or Her Client? [read post]
22 Mar 2007, 5:34 am
Danek Medical, Inc., 182 F.3d 281, 287 (4th Cir. 1999); In re Vitamins Antitrust Litigation, 183 Fed. [read post]
The full publication is available here. [1] R (KBR, Inc) v Director of the Serious Fraud Office [2021] UKSC [2] Section 72A(1) Pensions Act 2004 [3] Section 77(1A) Pensions Act 2004 [4] Section 77A Pensions Act 2004 [5] See, In re Vitamin Antitrust Litig., 2002 WL 35021999, at *28 (D.D.C. [read post]
21 Mar 2017, 2:04 pm by Robert E. Connolly
” [7] In other words, it isn’t fair to the government to have to litigate an issue where they would be bound if they lose, but the fugitive bears no risk because he can remain a fugitive if he loses. [read post]
9 Jan 2009, 3:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Humira (Adalimumab) – US: Bayer HealthCare files patent infringement suit against Abbott Laboratories over Humira; Abbott fires back with lawsuit claiming Bayer’s patent invalid, not infringed or unenforceable (Law360) (Law360) (Philip Brooks' Patent Infringement Updates) (Patent Baristas) Sprycel (Dasatinib)… [read post]
26 Apr 2013, 9:03 am by Rebecca Tushnet
Blood: No, they’re not planning to stop—they’re just ignoring the lawyer. [read post]
9 Aug 2008, 1:50 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: The end of William Patry’s blog: (Patry Copyright Blog), (Excess Copyright), (Patently-O), (Chicago IP Litigation Blog), (Michael Geist), (The Fire of Genius), (Techdirt), (Patry Copyright Blog), Kitchin J clarifies scope of biotech patents, in particular gene sequence patents: Eli Lilly & Co v Human Genome Sciences:… [read post]
30 May 2008, 9:09 am
: (Spicy IP), India: DCGI preparing document to implement patent-registration linkage: (Spicy IP), New Zealand: Generic pharmaceutical companies taking advantage of NZ IP laws and medicines regulations: (International Law Office), Uganda: Cipla licenses ARV technology into Uganda: (Afro-IP), US: Money saved through generic prescriptions: (GenericsWeb), US: Government plans to keep close tab on drug patent settlements: (GenericsWeb), US: FTC reports 14 deals to delay generics in 2007: (GenericsWeb),… [read post]
5 Sep 2008, 11:01 pm
(IP finance), Microsoft and Nikon sign patent cross-licensing agreement covering consumer electronics: (Managing Intellectual Property), World day against software patents: (Spicy IP), (IPKat), Patents.com – PatentMonkey redux: (The Patent Librarian’s Notebook), Women and patents: it is not working at the moment: (IAM) Experts discuss the role of IP in environmental technology transfer: (Intellectual Propery Watch), WIPO’s 2008 World Patent Report: (The Patent… [read post]
25 Jul 2008, 7:04 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: CAFC affirms validity and enforceability of Eisai’s compound patent on Aciphex; elucidates current standard for obviousness of chemical composition of matter patents: Eisai v Reddy’s Lab’s and Teva Pharma: (Orange Book Blog), (Patent Docs), (Patent Prospector), (IP Law360), (Hal Wegner), (Patent Baristas), Three-strikes scheme… [read post]